{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:47:23Z","timestamp":1775008043291,"version":"3.50.1"},"reference-count":34,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Succinate dehydrogenase\u2013deficient renal cell carcinoma (RCC) is a newly classified subtype of RCC in the World Health Organization classification of urinary and male genital tumours. However, systemic reports on this tumor are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To give new insights into the clinicopathologic and molecular features of succinate dehydrogenase complex iron sulfur subunit B (SDHB)\u2013deficient RCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Data from 5 SDHB-deficient RCC patients diagnosed at our hospital between 2016 and 2022 were collected and studied through light microscopy, immunohistochemistry (IHC), ultrastructural analysis, and Sanger sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>The median age of patients was 34 years; 2 were male and 3 were female. Grossly, the tumors were well defined, with an average diameter of 7 cm. Histologically, the cells were arranged in diverse patterns: solid, nested, glandular, or tubular with scattered cysts containing eosinophilic, wispy, or bubbly appearances. One patient\u2019s tumor exhibited an obvious papillary structure with focal aggregation of foam cells, and 3 tumors displayed focal micropapillary structures. Two patients presented with high-grade International Society of Urologic Pathology 3 nuclei. The tumor cells in all cases lacked SDHB expression by IHC stain. In addition, the average value of the combined positive score of programmed death ligand-1 (PD-L1, SP263) in all patients was 18. Electron microscopy revealed significant mitochondrial abnormalities. Genetic testing confirmed SDHB germline mutations in all tumors. One patient\u2019s tumor presented a novel, previously unreported mutation: c.697_700del in exon 7. Follow-up revealed metastasis in 1 patient, leading to mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Our findings broaden the morphologic spectrum and highlight a new point mutation in the SDHB gene, providing a genetic change spectrum for this tumor entity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2025-0233-oa","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:09:13Z","timestamp":1763744953000},"page":"310-316","source":"Crossref","is-referenced-by-count":0,"title":["New Insights Into Succinate Dehydrogenase\u2013Deficient Renal Cell Carcinoma: A Comprehensive Analysis of a Case Series With Novel Mutation Sites"],"prefix":"10.5858","volume":"150","author":[{"given":"Junfeng","family":"Wu","sequence":"first","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Wang","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizhen","family":"Hu","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linni","family":"Fan","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiao","family":"Xu","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"3","key":"i1543-2165-150-4-310-b01","series-title":"G Ital Nefrol","first-page":"vol3","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","unstructured":"Bahadoram S,\nDavoodi M,\nHassanzadeh S,\nBahadoram M,\nBarahman M,\nMafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):vol3."},{"issue":"3","key":"i1543-2165-150-4-310-b02","series-title":"World J Oncol","first-page":"79","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","unstructured":"Padala SA,\nBarsouk A,\nThandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79\u201387."},{"issue":"6","key":"i1543-2165-150-4-310-b03","series-title":"Int J Mol Sci","first-page":"3404","article-title":"Renal cell cancer and obesity","volume":"23","author":"Gluba-Brzozka","year":"2022","unstructured":"Gluba-Brzozka A,\nRysz J,\nLawinski J,\nFranczyk B. Renal cell cancer and obesity. Int J Mol Sci. 2022;23(6):3404."},{"issue":"1","key":"i1543-2165-150-4-310-b04","series-title":"Eur Urol","first-page":"93","article-title":"The 2016 WHO classification of tumors of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumors","volume":"70","author":"Moch","year":"2016","unstructured":"Moch H,\nCubilla A L,\nHumphrey P A,\nReuter VE,\nUlbright TM. The 2016 WHO classification of tumors of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumors. Eur Urol. 2016;70(1):93\u2013105."},{"issue":"12","key":"i1543-2165-150-4-310-b05","series-title":"Am J Surg Pathol","first-page":"1588","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","unstructured":"Gill AJ,\nHes O,\nPapathomas T, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38(12):1588\u20131602."},{"key":"i1543-2165-150-4-310-b06","series-title":"Urinary and Male Genital Tumours","volume":"8","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2022. WHO Classification of Tumours; vol 8."},{"issue":"10","key":"i1543-2165-150-4-310-b07","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"796","article-title":"Clinicopathological analysis of succinate dehydrogenase deficient renal cell carcinoma","volume":"48","author":"Xiao","year":"2019","unstructured":"Xiao Q,\nChen J,\nLiu D,\nWang CM,\nXu Q,\nGu XW. Clinicopathological analysis of succinate dehydrogenase deficient renal cell carcinoma. Zhonghua Bing Li Xue Za Zhi. 2019;48(10):796\u2013798."},{"issue":"1","key":"i1543-2165-150-4-310-b08","series-title":"Hum Genomics","first-page":"31","article-title":"Expanding ACMG variant classification guidelines into a general framework","volume":"16","author":"Masson","year":"2022","unstructured":"Masson E,\nZou WB,\nGenin E, et al. Expanding ACMG variant classification guidelines into a general framework. Hum Genomics. 2022;16(1):31."},{"issue":"1","key":"i1543-2165-150-4-310-b09","series-title":"BMC Neurol","first-page":"193","article-title":"Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report","volume":"22","author":"Koyama","year":"2022","unstructured":"Koyama S,\nOkabe Y,\nSuzuki Y, et al. Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report. BMC Neurol. 2022;22(1):193."},{"issue":"1","key":"i1543-2165-150-4-310-b10","series-title":"Am J Hum Genet","first-page":"153","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","unstructured":"Vanharanta S,\nBuchta M,\nMcwhinney SR, et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet. 2004;74(1):153\u2013159."},{"issue":"5","key":"i1543-2165-150-4-310-b11","series-title":"Arch Pathol Lab Med","first-page":"643","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma","volume":"143","author":"Tsai","year":"2019","unstructured":"Tsai TH,\nLee WY. Succinate dehydrogenase-deficient renal cell carcinoma. Arch Pathol Lab Med. 2019;143(5):643\u2013647."},{"key":"i1543-2165-150-4-310-b12","series-title":"Urol Case Rep","first-page":"101885","article-title":"Succinate dehydrogenase deficient renal cell carcinoma: a case report","volume":"40","author":"Kumar","year":"2022","unstructured":"Kumar RA,\nMiyagi H,\nMittal V,\nCrispen P,\nKumar U. Succinate dehydrogenase deficient renal cell carcinoma: a case report. Urol Case Rep. 2022;40:101885."},{"issue":"1","key":"i1543-2165-150-4-310-b13","series-title":"Mod Pathol","first-page":"80","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","unstructured":"Williamson SR,\nEble JN,\nAmin MB, et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol. 2015;28(1):80\u201394."},{"issue":"1","key":"i1543-2165-150-4-310-b14","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"12","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: a clinicopathological, ultrastructural and molecular analysis in [Chinese]","volume":"51","author":"Wang","year":"2022","unstructured":"Wang XT,\nWang X,\nZhang RS,\nCheng K,\nXia QY,\nRao Q. Succinate dehydrogenase-deficient renal cell carcinoma: a clinicopathological, ultrastructural and molecular analysis in [Chinese]. Zhonghua Bing Li Xue Za Zhi. 2022;51(1):12\u201316."},{"issue":"14","key":"i1543-2165-150-4-310-b15","series-title":"Shi Yong Yi Xue Za Zhi","first-page":"2304","article-title":"Clinicopathological features of succinic dehydrogenase-deficient renal cell carcinoma","volume":"35","author":"Wu","year":"2019","unstructured":"Wu J,\nCheng YH,\nZhang YJ, et al. Clinicopathological features of succinic dehydrogenase-deficient renal cell carcinoma. Shi Yong Yi Xue Za Zhi. 2019;35(14):2304\u20132307."},{"issue":"1","key":"i1543-2165-150-4-310-b16","series-title":"BMC Urol","first-page":"109","article-title":"SDH-deficient renal cell carcinoma\u2014clinical, pathologic and genetic correlates: a case report","volume":"18","author":"Kumar","year":"2018","unstructured":"Kumar R,\nBonert M,\nNaqvi A,\nZbuk K,\nKapoor A. SDH-deficient renal cell carcinoma\u2014clinical, pathologic and genetic correlates: a case report. BMC Urol. 2018;18(1):109."},{"issue":"12","key":"i1543-2165-150-4-310-b17","series-title":"J Cancer","first-page":"3596","article-title":"Determination of the expression of PD-L1 in the morphologic spectrum of renal cell carcinoma","volume":"11","author":"Walter","year":"2020","unstructured":"Walter B,\nGil S,\nNaizhen X, et al. Determination of the expression of PD-L1 in the morphologic spectrum of renal cell carcinoma. J Cancer. 2020;11(12):3596\u20133603."},{"issue":"3","key":"i1543-2165-150-4-310-b01","series-title":"G Ital Nefrol","first-page":"vol3","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","unstructured":"Bahadoram S,\nDavoodi M,\nHassanzadeh S,\nBahadoram M,\nBarahman M,\nMafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):vol3."},{"issue":"3","key":"i1543-2165-150-4-310-b02","series-title":"World J Oncol","first-page":"79","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","unstructured":"Padala SA,\nBarsouk A,\nThandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79\u201387."},{"issue":"6","key":"i1543-2165-150-4-310-b03","series-title":"Int J Mol Sci","first-page":"3404","article-title":"Renal cell cancer and obesity","volume":"23","author":"Gluba-Brzozka","year":"2022","unstructured":"Gluba-Brzozka A,\nRysz J,\nLawinski J,\nFranczyk B. Renal cell cancer and obesity. Int J Mol Sci. 2022;23(6):3404."},{"issue":"1","key":"i1543-2165-150-4-310-b04","series-title":"Eur Urol","first-page":"93","article-title":"The 2016 WHO classification of tumors of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumors","volume":"70","author":"Moch","year":"2016","unstructured":"Moch H,\nCubilla A L,\nHumphrey P A,\nReuter VE,\nUlbright TM. The 2016 WHO classification of tumors of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumors. Eur Urol. 2016;70(1):93\u2013105."},{"issue":"12","key":"i1543-2165-150-4-310-b05","series-title":"Am J Surg Pathol","first-page":"1588","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","unstructured":"Gill AJ,\nHes O,\nPapathomas T, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38(12):1588\u20131602."},{"key":"i1543-2165-150-4-310-b06","series-title":"Urinary and Male Genital Tumours","volume":"8","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2022. WHO Classification of Tumours; vol 8."},{"issue":"10","key":"i1543-2165-150-4-310-b07","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"796","article-title":"Clinicopathological analysis of succinate dehydrogenase deficient renal cell carcinoma","volume":"48","author":"Xiao","year":"2019","unstructured":"Xiao Q,\nChen J,\nLiu D,\nWang CM,\nXu Q,\nGu XW. Clinicopathological analysis of succinate dehydrogenase deficient renal cell carcinoma. Zhonghua Bing Li Xue Za Zhi. 2019;48(10):796\u2013798."},{"issue":"1","key":"i1543-2165-150-4-310-b08","series-title":"Hum Genomics","first-page":"31","article-title":"Expanding ACMG variant classification guidelines into a general framework","volume":"16","author":"Masson","year":"2022","unstructured":"Masson E,\nZou WB,\nGenin E, et al. Expanding ACMG variant classification guidelines into a general framework. Hum Genomics. 2022;16(1):31."},{"issue":"1","key":"i1543-2165-150-4-310-b09","series-title":"BMC Neurol","first-page":"193","article-title":"Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report","volume":"22","author":"Koyama","year":"2022","unstructured":"Koyama S,\nOkabe Y,\nSuzuki Y, et al. Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report. BMC Neurol. 2022;22(1):193."},{"issue":"1","key":"i1543-2165-150-4-310-b10","series-title":"Am J Hum Genet","first-page":"153","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","unstructured":"Vanharanta S,\nBuchta M,\nMcwhinney SR, et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet. 2004;74(1):153\u2013159."},{"issue":"5","key":"i1543-2165-150-4-310-b11","series-title":"Arch Pathol Lab Med","first-page":"643","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma","volume":"143","author":"Tsai","year":"2019","unstructured":"Tsai TH,\nLee WY. Succinate dehydrogenase-deficient renal cell carcinoma. Arch Pathol Lab Med. 2019;143(5):643\u2013647."},{"key":"i1543-2165-150-4-310-b12","series-title":"Urol Case Rep","first-page":"101885","article-title":"Succinate dehydrogenase deficient renal cell carcinoma: a case report","volume":"40","author":"Kumar","year":"2022","unstructured":"Kumar RA,\nMiyagi H,\nMittal V,\nCrispen P,\nKumar U. Succinate dehydrogenase deficient renal cell carcinoma: a case report. Urol Case Rep. 2022;40:101885."},{"issue":"1","key":"i1543-2165-150-4-310-b13","series-title":"Mod Pathol","first-page":"80","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","unstructured":"Williamson SR,\nEble JN,\nAmin MB, et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol. 2015;28(1):80\u201394."},{"issue":"1","key":"i1543-2165-150-4-310-b14","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"12","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: a clinicopathological, ultrastructural and molecular analysis in [Chinese]","volume":"51","author":"Wang","year":"2022","unstructured":"Wang XT,\nWang X,\nZhang RS,\nCheng K,\nXia QY,\nRao Q. Succinate dehydrogenase-deficient renal cell carcinoma: a clinicopathological, ultrastructural and molecular analysis in [Chinese]. Zhonghua Bing Li Xue Za Zhi. 2022;51(1):12\u201316."},{"issue":"14","key":"i1543-2165-150-4-310-b15","series-title":"Shi Yong Yi Xue Za Zhi","first-page":"2304","article-title":"Clinicopathological features of succinic dehydrogenase-deficient renal cell carcinoma","volume":"35","author":"Wu","year":"2019","unstructured":"Wu J,\nCheng YH,\nZhang YJ, et al. Clinicopathological features of succinic dehydrogenase-deficient renal cell carcinoma. Shi Yong Yi Xue Za Zhi. 2019;35(14):2304\u20132307."},{"issue":"1","key":"i1543-2165-150-4-310-b16","series-title":"BMC Urol","first-page":"109","article-title":"SDH-deficient renal cell carcinoma\u2014clinical, pathologic and genetic correlates: a case report","volume":"18","author":"Kumar","year":"2018","unstructured":"Kumar R,\nBonert M,\nNaqvi A,\nZbuk K,\nKapoor A. SDH-deficient renal cell carcinoma\u2014clinical, pathologic and genetic correlates: a case report. BMC Urol. 2018;18(1):109."},{"issue":"12","key":"i1543-2165-150-4-310-b17","series-title":"J Cancer","first-page":"3596","article-title":"Determination of the expression of PD-L1 in the morphologic spectrum of renal cell carcinoma","volume":"11","author":"Walter","year":"2020","unstructured":"Walter B,\nGil S,\nNaizhen X, et al. Determination of the expression of PD-L1 in the morphologic spectrum of renal cell carcinoma. J Cancer. 2020;11(12):3596\u20133603."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/4\/article-p310.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/doi\/10.5858\/arpa.2025-0233-OA\/3546562\/10.5858_arpa.2025-0233-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/4\/article-p310.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/4\/article-p310.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:33:42Z","timestamp":1775003622000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/4\/article-p310.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2025-0233-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}